Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Inducing melanoma for cancer vaccine development

28.03.2006
Cancer vaccines are being investigated in early-phase clinical trials around the world, with many of those trials recruiting patients with melanoma.

Although tumor regressions have been seen in 10% to 20% of patients with metastatic melanoma, the great promise of cancer vaccines - controlling tumor growth and cancer spread without serious side-effects - remains as yet unrealized. This could be set to change with the publication of a new mouse model technology in Cancer Research, the journal of the American Association of Cancer Research, from a multi-national team led by investigators at the Brussels Branch of the global Ludwig Institute for Cancer Research (LICR).

“Melanoma has been a focus of cancer vaccine development because many melanoma-specific vaccine targets, so-called ‘cancer antigens’, have been defined,” says the study’s senior author, LICR’s Dr. Benoit Van den Eynde. “However, we have a limited understanding of how most, but not all, melanomas evade an immune system that has been primed to detect and destroy cancer cells carrying one of these defined cancer antigens.”

According to Dr. Van den Eynde, this is due in part to the lack of appropriate animal models in which detailed immunological analyses can be performed before and after vaccination. “The models we use to investigate cancer vaccines at the preclinical level either have a defined cancer antigen in a transplanted tumor, or they have an ‘original’ tumor that doesn’t have a defined antigen. However, in human clinical studies, we have original tumors with defined antigens. So there has been a need for a mouse model that more closely follows the human model.”

Thus the Institute that first cloned mouse and human cancer antigens, allowing the rational design of cancer vaccines, has developed a model in which melanoma with a defined cancer antigen can be induced. The model has been engineered to have several mutations found to occur together in human melanoma, and so closely mimics the genetic profile of cancers treated in the clinic. The team, which is comprised of investigators from Belgium, France and The Netherlands, has already begun characterizing a cancer antigen-specific immune reaction observed before the mice were even vaccinated, which they hope will lead to a further understanding of spontaneous melanoma regressions.

Dr. Jill O’Donnell-Tormey, Executive-Director of New York’s Cancer Research Institute, which was founded in 1953 specifically to foster cancer immunology research, believes that this model may yield information crucial for cancer vaccines for other tumor types and not just melanoma. “We have clinical trials for cancer antigens for sarcoma, for melanoma, and for breast, prostate, lung and ovarian cancers. We’re learning a lot from these trials, but we could learn a lot more if we have a model like this, which selectively expresses each of our target antigens. Just one example might be the analysis of the immune response to cancer antigens during the early stages of cancer onset and progression, which might indicate if there is an optimum time for vaccination.”

Sarah White | alfa
Further information:
http://www.licr.org/C_news/archive.php/2006/03/27/inducing-melanoma-for-cancer-vaccine-development/

More articles from Life Sciences:

nachricht Less is more? Gene switch for healthy aging found
25.05.2018 | Leibniz-Institut für Alternsforschung - Fritz-Lipmann-Institut e.V. (FLI)

nachricht If solubilty is the problem - Mechanochemistry is the solution
25.05.2018 | Technische Universität Dresden

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Molecular switch will facilitate the development of pioneering electro-optical devices

A research team led by physicists at the Technical University of Munich (TUM) has developed molecular nanoswitches that can be toggled between two structurally different states using an applied voltage. They can serve as the basis for a pioneering class of devices that could replace silicon-based components with organic molecules.

The development of new electronic technologies drives the incessant reduction of functional component sizes. In the context of an international collaborative...

Im Focus: LZH showcases laser material processing of tomorrow at the LASYS 2018

At the LASYS 2018, from June 5th to 7th, the Laser Zentrum Hannover e.V. (LZH) will be showcasing processes for the laser material processing of tomorrow in hall 4 at stand 4E75. With blown bomb shells the LZH will present first results of a research project on civil security.

At this year's LASYS, the LZH will exhibit light-based processes such as cutting, welding, ablation and structuring as well as additive manufacturing for...

Im Focus: Self-illuminating pixels for a new display generation

There are videos on the internet that can make one marvel at technology. For example, a smartphone is casually bent around the arm or a thin-film display is rolled in all directions and with almost every diameter. From the user's point of view, this looks fantastic. From a professional point of view, however, the question arises: Is that already possible?

At Display Week 2018, scientists from the Fraunhofer Institute for Applied Polymer Research IAP will be demonstrating today’s technological possibilities and...

Im Focus: Explanation for puzzling quantum oscillations has been found

So-called quantum many-body scars allow quantum systems to stay out of equilibrium much longer, explaining experiment | Study published in Nature Physics

Recently, researchers from Harvard and MIT succeeded in trapping a record 53 atoms and individually controlling their quantum state, realizing what is called a...

Im Focus: Dozens of binaries from Milky Way's globular clusters could be detectable by LISA

Next-generation gravitational wave detector in space will complement LIGO on Earth

The historic first detection of gravitational waves from colliding black holes far outside our galaxy opened a new window to understanding the universe. A...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Save the date: Forum European Neuroscience – 07-11 July 2018 in Berlin, Germany

02.05.2018 | Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

Unique scope of UV LED technologies and applications presented in Berlin: ICULTA-2018

12.04.2018 | Event News

 
Latest News

If solubilty is the problem - Mechanochemistry is the solution

25.05.2018 | Life Sciences

Investigating cell membranes: researchers develop a substance mimicking a vital membrane component

25.05.2018 | Interdisciplinary Research

When corals eat plastics

24.05.2018 | Ecology, The Environment and Conservation

VideoLinks
Science & Research
Overview of more VideoLinks >>>